U.S. flag

An official website of the United States government

NM_020547.3(AMHR2):c.1332_1358del (p.Gly445_Leu453del) AND Persistent mullerian duct syndrome, type II

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 15, 2009
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000009159.2

Allele description [Variation Report for NM_020547.3(AMHR2):c.1332_1358del (p.Gly445_Leu453del)]

NM_020547.3(AMHR2):c.1332_1358del (p.Gly445_Leu453del)

Gene:
AMHR2:anti-Mullerian hormone receptor type 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q13.13
Genomic location:
Preferred name:
NM_020547.3(AMHR2):c.1332_1358del (p.Gly445_Leu453del)
HGVS:
  • NC_000012.12:g.53430189_53430215del
  • NG_015981.1:g.11335_11361del
  • NM_001164690.2:c.1328_1354del
  • NM_001164691.2:c.1140+564_1140+590del
  • NM_020547.3:c.1332_1358delMANE SELECT
  • NP_001158162.1:p.Trp443_Ser451del
  • NP_065434.1:p.Gly445_Leu453del
  • NC_000012.11:g.53823971_53823997del
  • NC_000012.11:g.53823973_53823999del
Note:
NCBI staff provided an HGVS expression for allelic variant 600956.0002 from the sequence reported in Figure 3 of the paper by Imbeaud et al., 1996 (PubMed 8872466).
Links:
OMIM: 600956.0002; dbSNP: rs764761319
NCBI 1000 Genomes Browser:
rs764761319
Molecular consequence:
  • NM_001164690.2:c.1328_1354del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_020547.3:c.1332_1358del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001164691.2:c.1140+564_1140+590del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Persistent mullerian duct syndrome, type II
Identifiers:
MedGen: C3897940

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000029376OMIM
no assertion criteria provided
Pathogenic
(Aug 15, 2009)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome.

Imbeaud S, Belville C, Messika-Zeitoun L, Rey R, di Clemente N, Josso N, Picard JY.

Hum Mol Genet. 1996 Sep;5(9):1269-77.

PubMed [citation]
PMID:
8872466

Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.

Belville C, Maréchal JD, Pennetier S, Carmillo P, Masgrau L, Messika-Zeitoun L, Galey J, Machado G, Treton D, Gonzalès J, Picard JY, Josso N, Cate RL, di Clemente N.

Hum Mol Genet. 2009 Aug 15;18(16):3002-13. doi: 10.1093/hmg/ddp238. Epub 2009 May 20.

PubMed [citation]
PMID:
19457927

Details of each submission

From OMIM, SCV000029376.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

Imbeaud et al. (1996) detected a 27-bp deletion (6331_6357del) in exon 10 of the AMHR gene, on at least 1 allele in 10 of 16 patients studied with AMHR mutations. The deletion was homozygous in 4 patients and was coupled with missense mutations in 6 patients.

Belville et al. (2009) noted that the 6331_6357del is missing residues 444 to 452, which are located at the top of the C-lobe in the X region of the kinase domain. Molecular modeling predicted that the deletion should lead to a substantial conformational change in the AMHR2 fold, since the residues constitute part of the alpha-G helix and the loop that precedes it.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024